International journal of nanomedicine

Improved Drug Delivery Methods to Increase Risperidone’s Absorption and Effectiveness

Updated

Abstract

Risperidone nano-microparticles may improve therapeutic effectiveness by enhancing solubility at the administration site.

  • Drugs classified under BCS Class II often have low absorption efficiency due to limitations in the dissolution phase.
  • Nanocarriers are proposed as a means to enhance drug delivery for disease diagnostics, therapy, and prevention.
  • The review discusses pharmaceutical compositions of risperidone nano-microparticles aimed at alleviating psychosis.
  • Potential future developments in drug delivery technologies are also highlighted.

Simplified

Key numbers

1.2–1.5×
Increase in
Relative increase of risperidone compared to free drug solution.
91% to 94%
Encapsulation Efficiency
Observed encapsulation efficiency range in liposomes developed for risperidone delivery.
111%
Increase with
of risperidone when delivered via .

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

The authors report no conflicts of interest in this work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free